CDK Inhibitors in Breast Cancer: Manageable Toxicity Profile CDK Inhibitors in Breast Cancer: Manageable Toxicity Profile

CDK inhibitors represent a new treatment option in HR+ breast cancer. A new review article shows that their overall toxicity is low and can be adequately managed.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news